MedTrace Logo

Community-acquired Pneumonia Due to Chlamydia Pneumoniae

NCT07679789 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 200

Last updated 2026-07-01

No results posted yet for this study

Summary

This international retrospective Franco-Swiss study focuses on community-acquired pneumonia (CAP) caused by Chlamydia pneumoniae.

The working hypothesis is that the prevalence of C. pneumoniae pneumonia is overestimated by the medical community.

The primary objective is to determine the true prevalence of C. pneumoniae infections among patients with pneumonia who underwent simplex or multiplex PCR testing.

Secondary objectives include;

1. Outpatient management
2. Hospitalization in a medical ward
3. Admission to the intensive care unit
4. In-hospital mortality
5. Radiological presentation of patients with community-acquired pneumonia (CAP) caused by Chlamydia pneumoniae
6. Prevalence of viral or bacterial co-infections associated with C. pneumoniae CAP

Conditions

  • Community-Acquired Pneumonia

Sponsors & Collaborators

  • Centre Hospitalier de Saint-Denis

    lead OTHER

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-06-30
Primary Completion
2026-09-30
Completion
2027-06-30

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07679789 on ClinicalTrials.gov